Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 467,728 | 376 | 615 | 788 |
| TOTAL | $N/A | $477,979 | $445 | $765 | $1,029 |
| Non-Current Assets | |||||
| PPE Net | N/A | 34 | N/A | N/A | N/A |
| Investments And Advances | 0 | 0 | 138,840 | 138,133 | 138,030 |
| Intangibles | 0 | 208 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 276 | 0 | 0 | 0 |
| TOTAL | $N/A | $518 | $138,840 | $138,133 | $138,030 |
| Total Assets | $N/A | $478,497 | $139,285 | $138,898 | $139,059 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 11,853 | 945 | 51 | 53 |
| Accrued Expenses | N/A | 6,117 | 2,863 | 1,784 | 55 |
| Other current liabilities | N/A | 4,147 | N/A | N/A | N/A |
| TOTAL | $N/A | $36,057 | $3,808 | $1,835 | $108 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 13,874 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 7,582 | 142,315 | 138,414 | 139,096 |
| TOTAL | $N/A | $12,374 | $147,145 | $143,244 | $143,926 |
| Total Liabilities | $N/A | $48,431 | $150,953 | $145,079 | $144,034 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 81,560 | 17,751 | 17,751 | 17,751 |
| Common Shares | N/A | 10,055 | 0 | 0 | 0 |
| Retained earnings | N/A | -140,036 | -11,669 | -6,181 | -4,975 |
| Other shareholders' equity | 0 | 4,422 | 0 | 0 | 0 |
| TOTAL | $N/A | $430,066 | $-11,668 | $-6,181 | $-4,975 |
| Total Liabilities And Equity | $0 | $478,497 | $139,285 | $138,898 | $139,059 |